MDxHealth Earnings Estimates, EPS & Revenue | NASDAQ:MDXH

Comments

MDxHealth SA Earnings Estimates

MDXHNASDAQ

Trade with Public

$3.20

-0.05-1.54%

At close: Mar 13, 5:00 PM EST

$3.25

0.051.56%

After Hours: Mar 12, 4:00 PM EST

Overview NewsEarningsGuidance Analyst Ratings Insider Trades Short Interest Stock Report

MDxHealth Earnings Estimates, EPS & Revenue | NASDAQ:MDXH

MDxHealth (MDXH) is scheduled to report Q1 earnings on May 13, 2026. Analysts estimate EPS of $-0.11 and quarterly revenue of $27.72M.

In the most recent quarter (Q4), MDxHealth reported EPS of $-0.17, missing estimates of $-0.13 by 0.31%. Revenue came in at $29.55M, exceeding the estimate of $26.02M by 0.14%.

MDxHealth has missed EPS estimates in 4 consecutive quarters.

Over the last 4 quarters, MDxHealth has averaged an EPS surprise of 0.96% and a revenue surprise of 0.07%.

Earnings Date

May 13

EPS Estimate

$-0.110

Quarterly Revenue Estimate

$27.72M

Annual Revenue
(as of Sep 30)

$103.07M

MDxHealth Earnings History

Analyze the earnings history of MDxHealth using advanced sorting and filters.

Loading calendar...

MDxHealth (MDXH) Earnings Per Share

The chart below shows MDxHealth's reported EPS compared to analyst estimates over recent quarters.

MDxHealth (MDXH) Revenue

The chart below shows MDxHealth's reported revenue compared to analyst estimates over recent quarters.

FAQ

When is MDxHealth (NASDAQ:MDXH) reporting earnings?

MDxHealth (MDXH) is scheduled to report earnings on May 13, 2026. The last reported earnings were for reported on February 26, 2026 for Q4.

What were the latest earnings per share (EPS) for MDxHealth (NASDAQ:MDXH)?

The Actual EPS was $-0.17, which missed the estimate of $-0.13.

What were MDxHealth’s (NASDAQ:MDXH) revenues?

The Actual Revenue was $29.55M, which beat the estimate of $26.02M.

People Also Watch

Molecular Partners AG

NASDAQ:MOLN

$4.56

8.06%

Kalaris Therapeutics Inc

NASDAQ:KLRS

$8.67

ProQR Therapeutics NV

NASDAQ:PRQR

$1.80

-1.10%

Connect Biopharma Holdings Ltd

NASDAQ:CNTB

$2.79

3.72%

Elicio Therapeutics Inc

NASDAQ:ELTX

$10.90

-10.66%

Whitehawk Therapeutics Inc

NASDAQ:WHWK

$3.81

-2.56%

Sangamo Therapeutics Inc

NASDAQ:SGMO

$0.38

0.48%

Tonix Pharmaceuticals Holding Corp

NASDAQ:TNXP

$13.25

0.08%

MDxHealth Earnings Estimates, EPS & Revenue | NASDAQ:MDXH

MDxHealth (MDXH) is scheduled to report Q1 earnings on May 13, 2026. Analysts estimate EPS of $-0.11 and quarterly revenue of $27.72M.

In the most recent quarter (Q4), MDxHealth reported EPS of $-0.17, missing estimates of $-0.13 by 0.31%. Revenue came in at $29.55M, exceeding the estimate of $26.02M by 0.14%.

MDxHealth has missed EPS estimates in 4 consecutive quarters.

Over the last 4 quarters, MDxHealth has averaged an EPS surprise of 0.96% and a revenue surprise of 0.07%.

Earnings Date

May 13

EPS Estimate

$-0.110

Quarterly Revenue Estimate

$27.72M

Annual Revenue
(as of Sep 30)

$103.07M